Johnson & Johnson (JNJ) EBT (2009 - 2026)

Johnson & Johnson has disclosed EBT across 18 years of filings, most recently posting $6.7 billion for Q2 2026.

• In Q2 2026, EBT rose 3.94% year-over-year to $6.7 billion; the TTM figure through Jun 2026 stood at $25.2 billion (down 7.87% YoY), while the FY2025 annual figure was $32.6 billion, up 95.25% from the prior year.
• EBT came in at $6.7 billion for Q2 2026 at Johnson & Johnson, up from $6.0 billion in the prior quarter.
• In the past five years, EBT ranged from a high of $13.6 billion in Q1 2025 to a low of -$1.3 billion in Q2 2023.
• Average EBT over 5 years is $5.4 billion, with a median of $5.2 billion recorded in 2022.
• Year-over-year, EBT tumbled 124.74% in 2023 and surged 388.58% in 2024.
• Over 5 years, EBT stood at $5.2 billion in 2022, then retreated by 6.69% to $4.8 billion in 2023, then dropped by 19.46% to $3.9 billion in 2024, then grew by 27.76% to $5.0 billion in 2025, then surged by 35.86% to $6.7 billion in 2026.
• Per Business Quant data, the three most recent EBT figures were $6.7 billion in Q2 2026, $6.0 billion in Q1 2026, and $5.0 billion in Q4 2025.